SS
TNYA icon

Steve Schonfeld’s Tenaya Therapeutics TNYA Stock Holding History

Steve Schonfeld’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-16,327
Closed -$11.3K – 3006
2026
Q1 		$11.3K Buy
+16,327
New +$12K ﹤0.01% 2085
2025
Q4 		– Sell
-465,957
Closed -$755K – 2585
2025
Q3 		$755K Buy
+465,957
New +$469K ﹤0.01% 1510
2024
Q4 		– Sell
-917,370
Closed -$1.77M – 2387
2024
Q3 		$1.77M Buy
917,370
+559,870
+157% +$1.58M 0.01% 935
2024
Q2 		$1.11M Buy
357,500
+167,500
+88% +$692K 0.01% 1165
2024
Q1 		$994K Buy
+190,000
New +$909K 0.01% 1234
2023
Q1 		– Sell
-11,100
Closed -$22.3K – 2651
2022
Q4 		$22.3K Sell
11,100
-7,000
-39% -$17.1K ﹤0.01% 2319
2022
Q3 		$52K Buy
+18,100
New +$84.5K ﹤0.01% 2639

Other funds holding TNYA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EAM
Empery Asset Management New York $86.5M AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
BGM
Burkehill Global Management New York $2.77B AUM 65.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Steve Schonfeld's TNYA Position: Q2 2026 in Review

Steve Schonfeld sold out of Tenaya Therapeutics (TNYA) in Q2 2026, closing a stake of 16,327 shares — an estimated $11.3K sold.

Steve Schonfeld first reported a position in TNYA in Q3 2022 and held it in 7 quarters. The position peaked at $1.77M in Q3 2024. 101 funds tracked by Wall St. Rank hold TNYA as of Q2 2026.

  • Steve Schonfeld reported no remaining Tenaya Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Steve Schonfeld sold 16,327 Tenaya Therapeutics shares in Q2 2026, an estimated $11.3K.
  • Steve Schonfeld first reported a position in Tenaya Therapeutics in Q3 2022 and held it in 7 quarters.
  • Steve Schonfeld's Tenaya Therapeutics position peaked at $1.77M in Q3 2024.
  • 101 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.